In Further Consolidation, GlaxoSmithKline (GSK) Shutters Pittsburgh Office, Eliminating 274 Jobs
Discovery Laboratories (DSCO) Ceasing Production of Lead Drug Surfaxin, Chops 50% Employees
Bristol-Myers Squibb (BMY) Soars After Halting Study Early As Opdivo Aces Test Again
AstraZeneca PLC (AZN)'s Experimental Lung Cancer Drug Delays Disease By More Than a Year
Takeda (TKPYY) Bets $269 Million+ with CiRA for 100-Scientist 10-Year Stem Cell R&D Pact
NeuroVive Chooses New Stroke Partner After To-BBB's Restructuring and Collaboration Concludes
Boston VC Firm Atlas Venture Set Sights on Biotech Startups With $280 Million Fund and New Home
DuPont Pioneer Joins a Handful of Illinois Companies with Layoffs But is Hush-Hush on Number
Athersys (ATHX) Craters as Stem Cell Therapy Fails Phase II Stroke Study
Investors Suddenly Interested in Synta (SNTA) and Its Upcoming Cancer Data
The Boston Biotechs That Are Expanding Their Employment Bases the Fastest
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial
Pfizer (PFE) Beams As Cancer Drug Efficacy Stops Trial Early and Analysts Predict Game Changer
Ex-Teva (TEVA) CEO Becomes Chief of Start-Up Ovid Therapeutics As Orphan Drugs Come Into Focus
Catalent Pharma Solutions (CTLT)' $52 Million Expansion Brings Hundreds of New Jobs to Kentucky
ThromboGenics NV (TBGNF) and VIB Form New Company to Research Roche (RHHBY)-Rejected Cancer Drug
Strand Life Sciences' 20 Employee U.S. Ops in Colorado Emerges From Stealth Mode
Aduro Biotech (ADRO) Launches $119 Million IPO with Hot Cancer Tech
See All News >
See All News >
//-->